Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:amendedBy |
gptkb:protein
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
Altimmune, Inc.
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALTU-238
|
| gptkbp:intendedUse |
treatment of diabetes
|
| gptkbp:mechanismOfAction |
long-acting human growth hormone
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:status |
clinical development
|
| gptkbp:target |
growth hormone deficiency
|
| gptkbp:bfsParent |
gptkb:Sollpura
|
| gptkbp:bfsLayer |
8
|